Purpose. To assess the frequency, the pattern of disease causing mutations, and phenotypic variations in patients with Leber congenital amaurosis (LCA) from Indonesia.
Introduction
Leber congenital amaurosis (LCA, MIM 204000, 204100 ) is a term used to refer to a group of inherited retinal dystrophies characterized by severe, bilateral visual impairment from birth (Leber, 1869) . LCA accounts for at least 5% of all retinal dystrophies and is one of the main causes of blindness in children (Heckenlively, 1988) .
LCA is generally inherited in an autosomal recessive manner although some autosomal dominant families have been described. To date, mutations in six genes have been reported to cause a subset of LCA. These include GUCY2D or RetGC1, encoding retinal guanylate cyclase (Perrault et al., 1996) ; RPE65, encoding a retinal pigment epithelium-specific 65 KD protein Felius et al., 2002; Hamel, Griffoin, Lasquellec, Bazalgette, & Arnaud, 2001; Lorenz et al., 2000; Lotery et al., 2000; Marcos, Ruiz, Borrego, & Antinolo, 2001; Marlhens et al., 1998; Morimura et al., 1998; Poehner et al., 2000; Simovich et al., 2001 ; Thompson et al., 2000) ; CRX, encoding the cone-rod homeobox-containing gene (Freund et al., 1997) ; AIPL1 (Sohocki et al., 2000) , CRB1 (Lotery et al., 2001 ) and RPGRIP (Dryja et al., 2001) . A severe early-onset retinal dystrophy with features suggesting LCA has been described with a mutation in the TULP1 gene, encoding the Tubby-like protein 1 (Hagstrom, North, Nishina, Berson, & Dryja, 1998) . The identification of these disease causing mutations raised the possibility of performing specific genotype-phenotype correlations that could be used to provide more accurate diagnostic and prognostic information to the patients.
Ethnic differences and geographic variations may affect the frequencies and pattern of mutations. So far molecular genetic studies of LCA are generally based on Caucasian populations. As Indonesian ophthalmologists do not satisfactorily perform the diagnosis of LCA, no data concerning LCA in Indonesian patients have been reported before. On the other hand recent data show that LCA patients carrying defects in the RPE65 gene are expected to be candidates for future therapeutic trials. Consequently for that reason, characterization of patients is an important issue to be explored.
There is a need to study this disease in Indonesian patients by identifying the kind and frequency of sequence variations present in the Indonesian population, performing genotype-phenotype correlations and to discover new sequence changes with clinical impact. This study was undertaken to identify and describe mutations in three genes (RetGC1, RPE65 and AIPL1) in Indonesian patients with LCA.
Patients and methods
Twenty-one unrelated individuals from The School of Blind and Paediatric Ophthalmology Clinic, Cipto Mangunkusumo Hospital University of Indonesia, clinically diagnosed by two of the authors (RS and BL) with LCA were screened for coding sequence mutations in RetGC1, RPE65 and AIPL1. Electroretinograms (ERGs) and visual field tests could not be performed due to the limited facilities available.
Blood samples were taken after informed consent according to The Declaration of Helsinki from affected individuals and, if available, from their relatives as well. DNA was extracted from peripheral blood lymphocytes according to (Miller, Dykes, & Polesky, 1988) . DNA samples were subjected to PCR to amplify the coding exons of RPE65, RetGC1 and AIPL1 genes using oligonucleotide primers previously reported (RetGC1, Perrault et al., 1996 and RPE65, Marlhens et al., 1997) . AIPL1 primers have been designed by the authors using the VECTOR NTI 7.0 Suite (VECTOR NTI Suite 7.0 (2001)). Subsequently, PCR products were analysed using single strand conformation polymorphism (SSCP) analysis. The PCR products presenting with aberrant electrophoretic patterns were subjected to direct sequencing using the fluorescent chain termination technique. To confirm the sequencing result, the PCR products of the patients, their relatives and controls were analyzed using restriction endonuclease assay when possible.
Results

Molecular results
We identified two disease-causing mutations in RPE65 and one in AIPL1 mutation of the 21 index cases studied. These mutations are summarized in Table 1 . Mutations in RetGC1 were identified but could not be proven with any degree of certainty to be disease-causing. In addition, a number of benign sequence variants within the RPE65, RetGC1 and AIPL1 genes were identified ( Table 2 ). Most of these variants identified were intronic.
RPE65 gene mutation
We identified a homozygous 9 bp in-frame deletion at nucleotide 106 (106del9bp) predicted to abolish three amino acids (LWL36del) in case 1 (II:2 in Fig. 1A) .
A missense mutation, G32V was identified in exon 3 of RPE65 in case 2 (II:4 in Fig. 1B ) at nucleotide 95. This mutation affects the first base pair of exon 3 and is considered to have an impact on splicing. The G32V mutation was confirmed using the TaaI-restriction enzyme. In the compound allele, an A fi G transition at nucleotide position 1304 in exon 12 was identified leading to the substitution of tyrosine by cysteine at amino acid position 435. The Y435C mutation creates a new Hpy8I restriction site. The sequencing results were confirmed by restriction digest. All three mutations were not present in any of 50 control individuals or in other probands tested.
No other family members were available for genetic testing in both families. So, segregation analysis was not possible.
AIPL1 gene mutation
The K14E mutation in AIPL1 is a novel mutation. The A fi G substitution at the first nucleotide of codon 14 in exon 1 leads to the substitution of a glutamine residue for a lysine residue. The K14E mutation cosegregated in the family in an autosomal recessive pattern. The K14E mutation creates a new XmnI restriction site (Fig. 2B) . It was not present in any of 60 unaffected individuals or in other probands tested. Fig. 1 shows the pedigrees, phenotypes and genotypes of the families carrying RPE65 mutations. In Fig. 2 the same data are summarized for the patients carrying the AIPL1 mutation. Table 3 summarizes the clinical findings. Family members available for clinical examination will be described in the following.
Clinical results
Case 1. The 106del9bp mutation in RPE65 was identified in case 1 (II:2 in Fig. 1A ), a 21 year-old patient. She was a child of a consanguineous marriage of unaffected parents, and had two affected brothers. She had a history of life long severe vision impairment. When examined at age 21, her visual acuity was restricted to the detection of hand movements in both eyes. Fine nystagmus was noted and the anterior segments were normal. Funduscopy showed attenuated vessels and pigment clumps in the peripheral retina. Fundus photographs of her were not available. Case 2. The compound heterozygous mutation G32V/Y435C in RPE65 was found in case 2 (II:4 in Fig.  1B) , a 23 year-old male. He completed normal school until age 9, by which time visual impairment had significantly progressed. At the age of 18 severe visual impairment was diagnosed. At the time of the examination the visual acuity was limited to light perception in both eyes. Fine nystagmus was noted, and the anterior segments were within the normal limit. Funduscopy showed attenuated retinal vessels, moderate pallor of the optic disc, areas of pigment epithelium atrophy and pigment clumps in the mid peripheral retina. In the macula and the surrounding superotemporal retina islands of marked hyperpigmentations were observed (Fig. 1E) .
Family 3. The homozygous K14E mutation in the AIPL1 gene was found in a female, 22 years of age (II:3 in Fig. 2A ). From birth, the parents of II:3 had noted an inability to move alone. However, systemic diseases were absent. Her visual acuity was insufficient to attend normal school since childhood and at the time of examination at the age of 22 years her it was restricted to hand movement and light perception. While the anterior segments were normal there were attenuated retinal vessel, hypopigmentation and bone spicule-like pigment deposits in the midperipheral retina (Fig. 2C/D) . The unrelated parents (I:1 and I:2) were both unaffected with normal anterior segments. While the father presented with a small macular drusen, the optic nerve head, fovea and retinal vessels were normal in both eyes. Her sister aged 6 years (II:6 in Fig. 2A ) was affected. The parents noted that this young girl had a marked visual impairment since birth. She could not follow objects and was unable to attend the school as a normal child. The digitoocular sign of Franceschetti (eye poking) was observed. Visual acuity was limited to hand movements in both eyes, and the anterior segments were normal. Due to the presence of marked pendular-jerk nystagmus fundus photography was not possible.
Discussion
This study is the first to be performed in patients from Indonesia diagnosed with LCA, which has previously been an under diagnosed, if not disregarded entity in Indonesia.
The prevalence of causative mutations of RPE65 for LCA has been estimated from 3.0% to 15.6% Lotery et al., 2000; Morimura et al., 1998; Simovich et al., 2001 ) although early and recurring reports have already put forward that RPE65 mutations cause an early onset severe retinal degeneration (EOSRD) which is phenotypically different from LCA (Gu et al., 1997; Lorenz et al., 2000; Thompson et al., 2000) . The important difference of EOSRD and LCA is a significantly better initial visual performance in EOSRD promising sufficient residual vision to attend regular schools until the early teen years. AIPL1 mutations were identified in 7-9% of LCA cases worldwide.
Our study was performed on a small set of index cases. The frequencies of mutations identified in RPE65 (9.5%) and in AIPL1 (4.8%) are in general accordance with previous studies Lotery et al., 2000; Morimura et al., 1998; Simovich et al., 2001; Sohocki et al., 2000) . Our findings, however, were in contrast with a study in the Indian population, which reported that RPE65 seems to be less involved in the causation of LCA (Joseph et al., 2002) . All index cases carrying the mutations were students at a School for Blind in Bandung with a total number of about 200 blind persons caused by different etiologies. Most of them come from West Java region with a total population of 35,000,611 in an area of 44,355 km 2 .
RPE65 mutations
The precise role of RPE65 has not been determined, however, it is clear that the protein has a crucial role in the metabolism of vitamin A in the visual cycle (Redmond et al., 1998) . Regeneration of the visual pigment is performed in the RPE, and requires the isomerisation of all trans-retinol to 11-cis-retinol, followed by the oxidation to 11-cis-retinal. In the absence of RPE65, the isomerisation process is blocked, leading to an accumulation of all-trans-retinyl esters (Redmond et al., 1998) . The distribution of disease causing mutations may be useful in identifying important functional domains. A most complete collection of RPE65 mutations can be obtained from the World Wide Web (http:// www.retina-international.org/sci-news/rpe65mut.htm).
The 106del9bp mutation in index case 1 has not been reported previously. It predicts an in-frame mutation and synthesis of a polypeptide shortened by three amino acids L36, W37 and L38. The amino acids W37 and L38 are conserved throughout the vertebrates from Homosapiens down to the Japanese firebelly newt Cynops pyrrogaster, whereas L36 is not. It is very likely that 106del9bp is predicting a functional null allele.
The compound heterozygous mutation G32V/Y435C identified in case 2 cannot be evaluated according to the affected protein domains since no domains have been described in RPE65. However, Gly 32 and Tyr 435 are conserved residues throughout the vertebrates from Homosapiens down to the Japanese firebelly newt Cynops pyrrogaster. It is presumed therefore, that these substitutions will lead to functional null alleles.
Correlations between LCA genotypes and the disease severity have been established for patients with RetGC1 (LCA1) and RPE65 mutations (LCA2) Perrault et al., 1999) . Several publications reported homozygous or compound heterozygous RPE65 mutations associated with cases of EOSRD (Felius et al., 2002; Gu et al., 1997; Lorenz et al., 2000) . In this present study a preserved visual function up to the age of about 9 years was noted in cases carrying RPE65 mutations, which afterwards progressed to almost total blindness during the second decade of life. Unfortunately we could not get any detailed information concerning the visual performance of these patients in early childhood as described by another studies . It is suggested that visual performance might be better during the first year of life, which may reflect postnatal physiological cone maturation .
Clinical characterisation of mutations in RPE65 and other RPE expressed genes involved in retinol metabolism suggest that impairment of the ocular metabolism of retinol predominantly affects rods (Hamel et al., 2001) . Our findings are in agreement with a mutation of RPE65 resulting in degeneration of the macular as previously suggested, as changes in the macular may reflect the greater density of rods over cones at the periphery of the macula.
AIPL1 mutations
AIPL1 has been reported to cause LCA4 (Sohocki et al., 2000) . It is a cytoplasmic protein with similarities to aryl hydrocarbon receptor-interacting protein (AIP), a member of the FK-506-binding protein family. It contains three tetratricopeptide repeats (TPR), a motif that is found in proteins with nuclear transport or protein chaperone activity, suggesting that AIPL1 may be involved in retinal protein folding or trafficking (Sohocki et al., 2000) . However, the exact function of AIPL1 remains unknown. Only a few data on AIPL1 mutations providing detailed clinical information were reported so far. In the present study cases II:3 and II:6 (Family 3) are homozygous for a K14E mutation. Lysine at this position is highly conserved in human, rat and mouse. It is likely, therefore, that this substitution represents a disease causing-mutation in this family.
Our data suggest that AIPL1 mutations cause a severe, early-onset blindness, a condition that can be distinguished from blindness in patients with the RPE65 mutation (LCA2). In both affected index cases (II:3 and II:6 in Family 3) total blindness was noted from infancy onwards. Pendular-jerk nystagmus and eye poking confirmed a severe perturbation of the development of visual function during the early stages of life. The severe, early-onset of blindness was also observed in our separated study in Caucasian patients harboring AIPL1 mutations (manuscript in preparation). This severe early onset of blindness may be due to a defect in the regulation of cell cycle progression during photoreceptor maturation. Thus, our data support that AIPL1 plays a role during early retinal development. It has been hypothesized that this gene is important in cytosolic stability and/or nuclear transport of NUB1 during regulation of cell cycle progression during photoreceptor maturation (Akey et al., 2002) .
The phenotype of AIPL1 mutations might be variable. Recently, it was reported that mutations in AIPL1 cause autosomal dominant cone-rod dystrophy (Sohocki et al., 2000) . AIPL1 mutations in our case segregated in an autosomal recessive pattern. Concerning the progression we were not able to distinguish between cone-rod and rod-cone progression. Indeed recent results by van der van der Spuy et al. (2002) indicate a rodspecific expression of AIPL1 which argues against a cone-rod progression.
As AIPL1 and RetGC1 were assigned closely on 17p13, both AIPL1 and RetGC1 should be screened for mutations in families with affected individuals whose LCA locus maps to 17p13, or in families with affected individuals who are homozygous for mutations in either gene, unless linkage excludes one of the genes by intragenic markers (Sohocki et al., 2000) . In our study the presence of RetGC1 mutation could be excluded by the mutational screening.
RetGC1 mutations
Mutations in RetGC1 gene have been identified in a large number of LCA families with the mutation frequency of 6.0-20.3% (Lotery et al., 2000) . Perrault et al., 2000) Our study could not identify any disease causing mutations in RetGC1, despite having screened the entire open reading frame of the gene. This may be due to the difference in the ethnic background between Indonesian patients and previously studied populations that had been recruited from countries surrounding the Mediterranean Sea (Hanein et al., 2002) . This introduces a bias in studies on patients from elsewhere.
In the present study we identified a frequent mutation (P701S) in 19 of 50 alleles in the heterozygote state including case 2, in whom a compound heterozygote RPE65 mutation was identified as disease-causing mutation. The P701S was reported previously as sequence variant which did not co-segregate with both of the affected probands in the family, but was detected only in the worse affected sibling in the pedigree . Further studies will be necessary to confirm whether this variation significantly alters the protein activity and how its interaction with other genes is involved in the pathogenesis of the disease.
In summary, the disease causing mutations identified in this study confirmed the diagnosis of LCA2 and LCA4, which has not been well described before in Indonesian patients. Phenotypically all the RPE65 and AIPL1 mutations identified caused total or almost total blindness in the second to third decade of life, but the onset of the blindness was considerably different. Patients with RPE65 mutation retain useful visual functions until the first decade, which is progressing to total blindness in the second to third decade of life. The patient with the AIPL1 mutation suffered from almost complete impairment of vision since birth. It is necessary, however, to conduct molecular screening studies in a larger scale on extended Indonesian families, to allow better recognition of pathogenicity of certain alleles and genotype-phenotype correlations.
